Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 2491 AL 2505

Potential Use of Calpain Inhibitors as Brain Injury Therapy

Cagmat EB, Guingab-Cagmat JD, Vakulenko AV, Hayes RL, Anagli J.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 40.

Huntington disease

Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ.

Nat Rev Dis Primers. 2015 Apr 23;1:15005. doi: 10.1038/nrdp.2015.5.

Huntington disease

Nat Rev Dis Primers. 2015 Apr 23;1:15052. doi: 10.1038/nrdp.2015.52.

How to make striatal projection neurons

Fjodorova M, Noakes Z, Li M.

Neurogenesis (Austin). 2015 Dec 15;2(1):e1100227. doi: 10.1080/23262133.2015.1100227. eCollection 2015.

Neurodegenerative Diseases: Where Are We Not Looking for Answers?

Koroshetz WJ, Mucke L.

In: Nikolich K, Hyman SE, editors. Translational Neuroscience: Toward New Therapies [Internet]. Cambridge (MA): MIT Press; 2015. Chapter 5.

Preclinical and Clinical Understanding: Major Gaps in Our Understanding and Capabilities

Koo EH.

In: Nikolich K, Hyman SE, editors. Translational Neuroscience: Toward New Therapies [Internet]. Cambridge (MA): MIT Press; 2015. Chapter 6.

Biparietal variant of Alzheimer's disease: a rare presentation of a common disease

Marques IB, Tábuas-Pereira M, Milheiro M, Santana I.

BMJ Case Rep. 2015 Jan 5;2015:bcr2014207011. doi: 10.1136/bcr-2014-207011.

Forkhead box G1 gene haploinsufficiency: an emerging cause of dyskinetic encephalopathy of infancy

Bertossi C, Cassina M, Cappellari A, Toldo I, Nosadini M, Rigon C, Suppiej A, Sartori S.

Neuropediatrics. 2015 Feb;46(1):56-64. doi: 10.1055/s-0034-1395345. Epub 2015 Jan 7.

Triheptanoin improves brain energy metabolism in patients with Huntington disease

Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, Valabregue R, Durr A, Mochel F.

Neurology. 2015 Feb 3;84(5):490-5. doi: 10.1212/WNL.0000000000001214. Epub 2015 Jan 7.

The human histaminergic system in neuropsychiatric disorders

Shan L, Bao AM, Swaab DF.

Trends Neurosci. 2015 Mar;38(3):167-77. doi: 10.1016/j.tins.2014.12.008. Epub 2015 Jan 7.

DNA triplet repeat expansion and mismatch repair

Iyer RR, Pluciennik A, Napierala M, Wells RD.

Annu Rev Biochem. 2015;84:199-226. doi: 10.1146/annurev-biochem-060614-034010. Epub 2015 Jan 2.

Flavonoid-based therapies in the early management of neurodegenerative diseases

Solanki I, Parihar P, Mansuri ML, Parihar MS.

Adv Nutr. 2015 Jan 15;6(1):64-72. doi: 10.3945/an.114.007500. Print 2015 Jan.

The impairment of cholesterol metabolism in Huntington disease

Leoni V, Caccia C.

Biochim Biophys Acta. 2015 Aug;1851(8):1095-105. doi: 10.1016/j.bbalip.2014.12.018. Epub 2015 Jan 14.

Rasagiline for the treatment of parkinsonism in Huntington's disease

Pérez-Pérez J, Martínez-Horta S, Pagonabarraga J, Carceller M, Kulisevsky J.

Parkinsonism Relat Disord. 2015 Mar;21(3):340-2. doi: 10.1016/j.parkreldis.2015.01.002. Epub 2015 Jan 10.

Repeat instability during DNA repair: Insights from model systems

Usdin K, House NC, Freudenreich CH.

Crit Rev Biochem Mol Biol. 2015 Mar-Apr;50(2):142-67. doi: 10.3109/10409238.2014.999192. Epub 2015 Jan 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias